Athenex, Inc. (ATNX): Price and Financial Metrics
ATNX Price/Volume Stats
|Current price||$0.20||52-week high||$23.80|
|Prev. close||$0.27||52-week low||$0.20|
|Day high||$0.26||Avg. volume||194,316|
|50-day MA||$1.15||Dividend yield||N/A|
|200-day MA||$4.04||Market Cap||1.76M|
ATNX Stock Price Chart Interactive Chart >
Athenex, Inc. (ATNX) Company Bio
Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.
ATNX Latest News Stream
|Loading, please wait...|
ATNX Latest Social Stream
View Full ATNX Social Stream
Latest ATNX News From Around the Web
Below are the latest news stories about ATHENEX INC that investors may wish to consider to help them evaluate ATNX as an investment opportunity.
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
SoFi Technologies (SOFI) stock is on the move Monday after the finance company's stock was hit with a downgrade Wedbush.
Athenex (ATNX) stock is falling on Monday after the company announced an agreement with lenders to pursue an expedited sales process.
Greenbrook TMS (GBNH) stock is on the move Monday as the therapy center prepares to release its latest earnings report later today.
On Sunday, Athenex Inc (NASDAQ: ATNX) and certain of its subsidiaries voluntarily filed for Chapter 11 proceedings. Athenex agreed with its lenders to move forward with an expedited sale process of its assets, the company said in a statement. The company has listed estimated assets and liabilities of around $100 million-$500 million, Reuters reported citing a filing with the U.S. Bankruptcy Court for the Southern District of Texas. The company said the assets would be sold across its primary bus
ATNX Price Returns